arrow
R

Roy Lalisang

maastricht university hospital
H指数:29
被引数:3,630

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Health-Related Quality of Life in Adolescents and Young Adults With an Uncertain or Poor Cancer Prognosis: Quantitative Baseline Results of the CORD-AYA Study

癌症预后不确定或不良的青少年和年轻成年人的健康相关生活质量:CORD-AYA研究的定量基线结果

2025-11-210
OAAI
Associations of adherence to the World Cancer Research Fund lifestyle recommendations with health-related quality of life and fatigue in Adolescent and Young Adult (AYA) cancer survivors: results from the SURVAYA study

世界癌症研究基金会生活方式建议的依从性与健康相关生活质量及疲劳在青少年和年轻成人(AYA)癌症幸存者中的关联:SURVAYA研究的结果

2025-09-080
OAAI
Health-related quality of life of long-term adolescent and young adult (AYA) cancer survivors compared to a matched normative population: results of the SURVAYA study

长期青少年及年轻成人(AYA)癌症幸存者的健康相关生活质量与匹配的常模人群的比较:SURVAYA研究的结果

2025-06-170
OAAI
Safety of dostarlimab in combination with chemotherapy in patients with primary advanced or recurrent endometrial cancer in a phase III, randomized, placebo-controlled trial (ENGOT-EN6-NSGO/GOG-3031/RUBY)
2024-09-280
OAAI
Pre-treatment fertility preservation and post-treatment reproduction in long-term survivors of adolescent and young adult (AYA) cancer
2024-02-064
OAAI
Adherence to the World Cancer Research Fund/American Institute for Cancer Research recommendations for cancer prevention in adolescent and young adult (AYA) cancer survivors: results from the SURVAYA study

遵守世界癌症研究基金会/美国癌症研究所关于青少年和年轻成人 (AYA) 癌症幸存者癌症预防的建议: SURVAYA研究的结果

2024-01-150
OAAI
Phenotype-guided targeted therapy based on functional signal transduction pathway activity in recurrent ovarian cancer patients: The STAPOVER study protocol

基于复发性卵巢癌患者功能性信号转导通路活性的表型指导靶向治疗: STAPOVER研究方案

HELIYON
IF3.6
2024-01-011
OAAI
Finding my way in a maze while the clock is ticking: The daily life challenges of adolescents and young adults with an uncertain or poor cancer prognosis
2022-11-1514
OAAI
Development and external validation of a prediction model for tube feeding dependency for at least four weeks during chemoradiotherapy for head and neck cancer
2022-01-019
OAAI
Impact of hormonal biomarkers on response to hormonal therapy in advanced and recurrent endometrial cancer
2021-10-0116
OAAI
Strong vaccine responses during chemotherapy are associated with prolonged cancer survival

化疗期间强烈的疫苗反应与延长癌症生存期有关

2020-03-1890
OAAI
A strong HPV-specific T-cell response after chemo-immunotherapy for advanced cervical cancer is associated with prolonged survival
2019-07-012
PRE